Pneumatic Compression Stockings During Hemodialysis

Hemodialysis Clinical Trial

Official title:

The Effect of Pneumatic Compression Stockings on Hemodynamic Parameters in Hemodialysis Patients: A Randomized Crossover Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01067170
• Other study ID #: E-21937
• Status: Completed
• Phase: N/A
• First received: February 9, 2010
• Last updated: December 12, 2012
• Start date: November 2008
• Est. completion date: August 2012

Study information

• Verified date: December 2012
• Source: University of Calgary
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study aims to determine the effect of pneumatic compression devices (PCDs) on central blood volume in hemodialysis patients. We hypothesize that PCDs will help maintain central blood volume, and therefore prevent sudden decreases in blood pressure during hemodialysis.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 51
• Est. completion date: August 2012
• Est. primary completion date: February 2011
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• on hemodialysis at least 3 months

• on hemodialysis at least 3 times per week

Exclusion Criteria:

• dialyzing with a central venous catheter

• vascular access dysfunction

• peripheral vascular disease

• active medical issue

• unable to provide informed consent

Related Conditions & MeSH terms

• Hemodialysis

Intervention

Device:
• Pneumatic Compression Stockings
Thigh-high pneumatic compression stockings

Locations

Country	Name	City	State
Canada	University of Calgary	Calgary	Alberta

Sponsors (1)

Lead Sponsor	Collaborator
University of Calgary

Country where clinical trial is conducted

Canada, 

References & Publications (1)

Tai DJ, Ahmed SB, Palacios-Derflingher L, Hemmelgarn BR, MacRae JM; Alberta Kidney Disease Network. Pneumatic compression devices during hemodialysis: a randomized crossover trial. Nephrol Dial Transplant. 2013 Apr;28(4):982-90. doi: 10.1093/ndt/gfs502. E — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Central blood volume		pre and post hemodialysis
Secondary	cardiac output		pre and post hemodialysis
Secondary	cardiac index		pre and post hemodialysis
Secondary	systemic vascular resistance		pre and post hemodialysis
Secondary	intracellular fluid volume		pre and post hemodialysis
Secondary	extracellular fluid volume		pre and post hemodialysis
Secondary	total body water		pre and post hemodialysis